CompletedNot Applicable

Towards A Better Paradigm for Head and Neck Cancer Treatment Applying Artificial Intelligence. HNC-TACTIC.

Spain10,000 participantsStarted 2021-12-06

Plain-language summary

This will be an international, multicenter, retrospective, observational, and data-driven study using secondary data captured in EHRs. The extraction of the data captured in the EHRs will be performed with SAVANA's EHRead®, an innovative data-driven system based on Natural Language Processing (NLP) and machine learning. For all patients, the Index Date is defined as the timepoint within the study period when they fulfill ALL inclusion criteria and no exclusion criteria. Follow-up comprises the period between Index Date and the last EHR available within the study period. Additional variable-specific time windows may be considered to optimize data collection.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients ≥18 years old. * Patients diagnosed with HNSCC * For selected exploratory analyses, patients diagnosed with nasopharynx, paranasal sinus, and salivary gland tumors. Exclusion Criteria: * Patients with follow-up of less than 6 months, except if deceased (any cause) in the 6 months after HNSCC diagnosis

What they're measuring

Predictive model based on dynamic risk stratification (DRS) for the risk of recurrence or disease progression

Timeframe: From 1st Jan 2021

Predictive model based on dynamic risk stratification (DRS) aimed at identifying patients' features

Timeframe: From 1st Jan 2021

Trial details

NCT IDNCT05117775

SponsorSavana Research

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2024-02-28

View on ClinicalTrials.gov More Head and Neck Cancer trials